Home Government Fed agency turns to Regeneron for first drugs against MERS

Fed agency turns to Regeneron for first drugs against MERS

SHARE

Regeneron lab scientists have identified two antibodies to potentially prevent and treat highly fatal Middle East Respiratory Syndrome.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.

Non members are only allowed 10 clicks per month

Print Friendly